istock-664596068_golden_brown
golden_brown / iStockphoto.com
20 February 2018Americas

Biotech groups slam Malaysia, Canada and Korea in Special 301 comments

Trade associations Pharmaceutical Research and Manufacturers of America (PhRMA) and Biotechnology Innovation Organization (BIO) have called for Malaysia to be placed on the US Trade Representative’s (USTR) watch list in its “2018 Special 301 Report”.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Africa
29 April 2016   The Biotechnology Innovation Organization has welcomed the US Trade Representative’s “Special 301 Report”, which it said “aims to advance global IP rights in biotechnology in a number of constructive ways”.
Americas
13 February 2017   The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.
Americas
18 March 2019   Supranational organisations such as the World Health Organization and the United Nations Development Program are promoting acts, policies and practices that prevent biopharmaceutical innovators from securing and maintaining patents.

More on this story

Africa
29 April 2016   The Biotechnology Innovation Organization has welcomed the US Trade Representative’s “Special 301 Report”, which it said “aims to advance global IP rights in biotechnology in a number of constructive ways”.
Americas
13 February 2017   The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.
Americas
18 March 2019   Supranational organisations such as the World Health Organization and the United Nations Development Program are promoting acts, policies and practices that prevent biopharmaceutical innovators from securing and maintaining patents.

More on this story

Africa
29 April 2016   The Biotechnology Innovation Organization has welcomed the US Trade Representative’s “Special 301 Report”, which it said “aims to advance global IP rights in biotechnology in a number of constructive ways”.
Americas
13 February 2017   The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.
Americas
18 March 2019   Supranational organisations such as the World Health Organization and the United Nations Development Program are promoting acts, policies and practices that prevent biopharmaceutical innovators from securing and maintaining patents.